Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 0 | 248 |
| Gross Profit | N/A | N/A | N/A | N/A | 248 |
| Operating Expenses | 60,639 | 52,392 | 47,037 | 47,685 | 47,576 |
| Operating Income | -60,639 | -52,392 | -47,037 | -47,685 | -47,328 |
| Interest Expense | 868 | 445 | 320 | 317 | 319 |
| Other Income | 5,653 | 5,882 | 6,248 | 6,515 | 6,455 |
| Pre-tax Income | -55,854 | -46,955 | -41,109 | -41,487 | -41,192 |
| Net Income Continuous | -55,854 | -46,955 | -41,109 | -41,487 | -41,192 |
| Net Income | $-55,854 | $-46,955 | $-41,109 | $-41,487 | $-41,192 |
| EPS Basic Total Ops | -0.92 | -0.78 | -0.68 | -0.70 | -0.70 |
| EPS Basic Continuous Ops | -0.93 | -0.78 | -0.69 | -0.70 | -0.70 |
| EPS Diluted Total Ops | -0.92 | -0.78 | -0.68 | -0.70 | -0.70 |
| EPS Diluted Continuous Ops | -0.93 | -0.78 | -0.69 | -0.70 | -0.70 |
| EPS Diluted Before Non-Recurring Items | -0.92 | -0.78 | -0.69 | N/A | N/A |
| EBITDA(a) | $-60,164 | $-50,788 | $-41,348 | $-50,940 | $-50,779 |